Freyja H M van Lint - JoVE Visualize

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

European Journal of Heart Failure|April 23, 2025

Age-related penetrance of phospholamban p.Arg14del cardiomyopathyTom E Verstraelen, Freyja H M van Lint, Remco de Brouwer, et al.

Journal of Cardiovascular Translational Research|June 25, 2026

Tracing the pathogenic PLN p.(Arg14del) variant across the globe; more than just a local curiosityEsmée van Drie, Freyja H M van Lint, Rob Zwart, et al.

Circulation. Genomic and Precision Medicine|December 29, 2022

Variant Location Is a Novel Risk Factor for Individuals With Arrhythmogenic Cardiomyopathy Due to a Desmoplakin (DSP) Truncating VariantEdgar T Hoorntje, Charlotte Burns, Luisa Marsili, et al.

Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

European Journal of Heart Failure|April 23, 2025

Age-related penetrance of phospholamban p.Arg14del cardiomyopathyTom E Verstraelen, Freyja H M van Lint, Remco de Brouwer, et al.

Journal of Cardiovascular Translational Research|June 25, 2026

Tracing the pathogenic PLN p.(Arg14del) variant across the globe; more than just a local curiosityEsmée van Drie, Freyja H M van Lint, Rob Zwart, et al.

Circulation. Genomic and Precision Medicine|December 29, 2022

Variant Location Is a Novel Risk Factor for Individuals With Arrhythmogenic Cardiomyopathy Due to a Desmoplakin (DSP) Truncating VariantEdgar T Hoorntje, Charlotte Burns, Luisa Marsili, et al.

Pageof 2